| 1 |
28099148 | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells. | 2017 Mar 14 |
1 |
| 2 |
27474150 | FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer. | 2016 Oct |
1 |
| 3 |
27863490 | Suberoylanilide hydroxamic acid represses glioma stem-like cells. | 2016 Nov 18 |
1 |
| 4 |
24651472 | Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulation. | 2014 |
1 |
| 5 |
23590818 | Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells. | 2013 Aug |
3 |
| 6 |
23868066 | SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma. | 2013 Jul 18 |
1 |
| 7 |
24236158 | The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. | 2013 |
1 |
| 8 |
22154545 | Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent. | 2012 May |
2 |
| 9 |
22322857 | Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. | 2012 Aug |
1 |
| 10 |
23086637 | [Synergistic effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid with imatinib on K562 cells]. | 2012 Sep |
1 |
| 11 |
19387079 | Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications. | 2009 Sep |
1 |
| 12 |
19597472 | Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. | 2009 Sep 3 |
2 |
| 13 |
19737941 | Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression. | 2009 Sep |
1 |
| 14 |
18636153 | The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. | 2008 Aug |
1 |
| 15 |
18765530 | Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. | 2008 Sep 1 |
1 |
| 16 |
18787411 | Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. | 2008 Oct |
2 |
| 17 |
17351739 | SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. | 2007 Jul |
1 |
| 18 |
18025281 | Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells. | 2007 Nov |
1 |
| 19 |
18065490 | Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells. | 2007 Dec |
2 |
| 20 |
16550602 | The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. | 2006 Aug 15 |
1 |
| 21 |
15897598 | Novel histone deacetylase inhibitors in the treatment of thyroid cancer. | 2005 May 15 |
1 |